Clinical Trial Update: Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

View source ↗

Summary

A centralized Pan-Middle East survey evaluating undertreatment of hypercholesterolemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Status: COMPLETED